arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Oric Pharmaceuticals, Inc.

ORIC Health Care Biotechnology: Pharmaceutical Preparations
$12.97
▼ -6.3% Today
as of Oct 23, 11:50 ET
Last 30 days +2.37% Sep 14 → Oct 23
$11.11 $11.84 $12.58 $13.32 $14.05 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$13.57
High
$14.14
Low
$13.38
Volume
$1M
Avg Vol
$2M
Mkt Cap
$1.3B
P/E (TTM)
—
Beta
—
52w High
$14.68
52w Low
$7.23
Div Yield
—
Shares Out
$104M

Recent Press Releases & News last 60 days · 14 items

Oct 23 · 09:53 MT Newswires
ORIC to Advance Lung Cancer Drug Candidate to Phase 3 Trial
Oct 23 · 07:15 PR GlobeNewswire
ORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 Trial
Oct 23 · 07:15 PR GlobeNewswire
ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026
▸ Show all 14 press releases & news Free account →

ORIC earnings at a glance

The options market is pricing a move of about ±18.7% after the report, a range of roughly $10.54 to $15.40 from today's $12.97. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±1.0% on average; after the most recent report on May 4, 2026 it moved -1.4%. That means options currently expect more movement than ORIC has typically delivered. ORIC beat the consensus EPS estimate in 2 of its last 4 reported quarters. Implied volatility is currently 158%. The share price of $12.97 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$7.23
$15
77% of range
Avg surprise (last 4)
+6.3%
Avg reaction (last 2)
-0.5%
50% positive
Latest IV / EM
158%
EM ±18.7% · $12 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.53$-0.48$-0.42$-0.36$-0.31 Actual $-0.53Actual $-0.50Actual $-0.44Actual $-0.37Actual $-0.45Actual $-0.49Actual $-0.42Est $-0.51Actual $-0.47Est $-0.46Actual $-0.33Est $-0.41Actual $-0.34Est $-0.31Actual $-0.38 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-41M$-39M$-37M$-34M$-32M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.38 — — — — financials
Mon May 4, 2026Mar/2026 $-0.34 $-0.31 -9.7% +19.1% -1.4% earnings
Thu Nov 13, 2025Sep/2025 $-0.33 $-0.41 +19.5% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.47 $-0.46 -2.2% — — earnings
Mon May 5, 2025Mar/2025 $-0.42 $-0.51 +17.6% — +0.5% earnings
Mon Sep 30, 2024Sep 2024 $-0.49 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.45 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.37 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.44 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.50 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.53 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-45M$-40M—$-37M$-39M$-33M—$-38M
Net income$-41M$-36M—$-33M$-36M$-30M—$-35M
EPS (diluted)$-0.38$-0.34—$-0.33$-0.47$-0.42—$-0.49

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$37M$56M$46M$50M$76M$49M$59M$44M
Inventory————————
Total current assets$274M$290M$288M$296M$291M$211M$262M$279M
Total assets$405M$437M$409M$431M$347M$243M$274M$302M
Long-term debt————————
Total liabilities$23M$21M$25M$24M$23M$23M$31M$28M
Total equity$381M$416M$384M$407M$324M$220M$243M$274M

Implied volatility — last 90 days

49%205%362%518%675% Jun 10 — IV 578% · EM ±68.3%Jun 22 — IV 276% · EM ±57.6%Jun 25 — IV 270% · EM ±52.9%Jun 26 — IV 275% · EM ±52.6%Jun 29 — IV 144% · EM ±25.6%Jul 01 — IV 209% · EM ±34.9%Jul 02 — IV 266% · EM ±43.0%Jul 03 — IV 275% · EM ±43.0%Jul 06 — IV 311% · EM ±43.1%Jul 20 — IV 146% · EM ±34.5%Jul 22 — IV 132% · EM ±30.2%Jul 23 — IV 157% · EM ±35.4%Jul 24 — IV 186% · EM ±41.1%Jul 27 — IV 144% · EM ±30.0%Jul 28 — IV 206% · EM ±42.2%Jul 29 — IV 204% · EM ±40.8%Jul 30 — IV 191% · EM ±37.4%Aug 03 — IV 288% · EM ±50.9%Aug 04 — IV 218% · EM ±37.5%Aug 05 — IV 112% · EM ±18.8%Aug 06 — IV 103% · EM ±16.6%Aug 07 — IV 106% · EM ±16.6%Aug 10 — IV 257% · EM ±35.6%Aug 13 — IV 309% · EM ±36.4%Aug 18 — IV 100% · EM ±7.2%Aug 24 — IV 60% · EM ±12.6%Aug 26 — IV 96% · EM ±19.2%Aug 27 — IV 189% · EM ±37.1%Aug 28 — IV 49% · EM ±9.4%Sep 02 — IV 228% · EM ±38.1%Sep 03 — IV 246% · EM ±39.7%Sep 09 — IV 211% · EM ±26.4%Sep 10 — IV 242% · EM ±28.6%Sep 11 — IV 162% · EM ±17.9%Sep 14 — IV 322% · EM ±26.9%Sep 16 — IV 675% · EM ±39.9%Sep 21 — IV 140% · EM ±29.2%Sep 22 — IV 199% · EM ±40.7%Sep 23 — IV 119% · EM ±23.8%Sep 24 — IV 134% · EM ±26.2%Sep 25 — IV 145% · EM ±27.7%Sep 28 — IV 124% · EM ±22.0%Sep 29 — IV 165% · EM ±28.4%Sep 30 — IV 179% · EM ±29.9%Oct 01 — IV 212% · EM ±34.3%Oct 02 — IV 262% · EM ±41.0%Oct 05 — IV 143% · EM ±19.9%Oct 06 — IV 106% · EM ±14.0%Oct 07 — IV 169% · EM ±21.2%Oct 08 — IV 158% · EM ±18.7%

Sector peers

DMRA
Damora Therapeutics, Inc.
$1.2B $20.81-3.3%
TYRA
Tyra Biosciences, Inc.
$1.4B $20.63+0.1%
AVBP
ArriVent BioPharma, Inc.
$1.4B $18.53-3.1%
GHRS
GH Research PLC
$1.4B $18.05-4.5%
RARE
Ultragenyx Pharmaceutical Inc.
$1.5B $15.63-1.8%
MNKD
MannKind Corporation
$1.1B $3.17+3.8%

ORIC earnings FAQ

What is ORIC's expected move for earnings?

Options currently price a move of about ±18.7%, or $2.43 per share either way from $12.97.

How does ORIC stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.0%, up 1 times and down 1 times.

What is ORIC's implied volatility?

ORIC's at-the-money implied volatility is about 158% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in